WO2001064840A8 - Novel bone marrow nucleic acids and polypeptides - Google Patents
Novel bone marrow nucleic acids and polypeptidesInfo
- Publication number
- WO2001064840A8 WO2001064840A8 PCT/US2001/006509 US0106509W WO0164840A8 WO 2001064840 A8 WO2001064840 A8 WO 2001064840A8 US 0106509 W US0106509 W US 0106509W WO 0164840 A8 WO0164840 A8 WO 0164840A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bone marrow
- nucleic acids
- polypeptides
- novel bone
- marrow nucleic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
L'invention porte sur de nouveaux acides nucléiques exprimés par la moelle osseuse, sur de nouvelles séquences de polypeptides codées par lesdits acides, et sur leurs utilisations.The invention relates to new nucleic acids expressed by bone marrow, to new sequences of polypeptides encoded by said acids, and to their uses.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001241873A AU2001241873A1 (en) | 2000-02-28 | 2001-02-28 | Novel bone marrow nucleic acids and polypeptides |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51512600A | 2000-02-28 | 2000-02-28 | |
US09/515,126 | 2000-02-28 | ||
US57740900A | 2000-05-18 | 2000-05-18 | |
US09/577,409 | 2000-05-18 | ||
US25058300P | 2000-11-30 | 2000-11-30 | |
US60/250,583 | 2000-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001064840A2 WO2001064840A2 (en) | 2001-09-07 |
WO2001064840A8 true WO2001064840A8 (en) | 2002-03-21 |
Family
ID=27400340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/006509 WO2001064840A2 (en) | 2000-02-28 | 2001-02-28 | Novel bone marrow nucleic acids and polypeptides |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001241873A1 (en) |
WO (1) | WO2001064840A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2396352B (en) * | 2000-02-04 | 2004-08-25 | Aeomica Inc | Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
WO2003006990A1 (en) * | 2001-07-12 | 2003-01-23 | Exelixis, Inc. | Modifiers of the p21 pathway and methods of use |
-
2001
- 2001-02-28 WO PCT/US2001/006509 patent/WO2001064840A2/en active Application Filing
- 2001-02-28 AU AU2001241873A patent/AU2001241873A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2001241873A1 (en) | 2001-09-12 |
WO2001064840A2 (en) | 2001-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE469911T1 (en) | ISOLATED NUCLEIC ACID MOLECULES ENCODING T-CELL INDUCIBLE FACTORS (TIF), ENCODED PROTEINS AND THEIR APPLICATIONS | |
TR200100056T2 (en) | Neurotrophic factors | |
ATE444967T1 (en) | SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 | |
YU19903A (en) | Novel receptor nucleic acids and polypeptides | |
DE60144145D1 (en) | Subtilisin variant | |
EP1067182A3 (en) | Secretory protein or membrane protein | |
WO2001064834A8 (en) | Novel nucleic acids and polypeptides | |
BR0113286A (en) | Substituted pyrazoles | |
CY1111750T1 (en) | Neurotrophic factors | |
CY1107628T1 (en) | HUMAN CTLA-4 ANTIBODIES AND USES | |
DE69637844D1 (en) | NEW TGF-BETA-SIMILAR CYTOKIN | |
WO2002014485A3 (en) | Kallikrein gene | |
SE9801455D0 (en) | New receptor | |
ATE439441T1 (en) | MODIFIED FLUORESCENT PROTEINS | |
PT1290160E (en) | PELLINO HUMAN POLIPEPTIDEES | |
ATE369429T1 (en) | STRUCTURAL PROTEINS OF THE VIRUS CAUSING PANCREAS DISEASE IN FISH AND THEIR USES | |
SE9602822D0 (en) | New receptor | |
DK0939769T3 (en) | The vertebrate Smoothened proteins | |
WO2001064840A8 (en) | Novel bone marrow nucleic acids and polypeptides | |
BR0014167A (en) | Proteìna iren, its preparation and application | |
ATE265418T1 (en) | NEW SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES | |
NO20021429D0 (en) | 1,4-dioxacycloalkan-2-one and 1,4-dioxacycloalken-2-one | |
ATE412753T1 (en) | ANTIBACTERIAL PROTEIN CHLAMYSIN-B, GENE CODING THEREOF AND AN EXPRESSION SYSTEM THEREOF | |
IT1320082B1 (en) | PROCEDURE FOR THE CREATION OF BRA, AS WELL AS BRA 'OBTAINED. | |
ITMI20001056A0 (en) | CODING POLYNUCLEOTIDES FOR POLYMORPHIC FORMS OF THE PTHRP PROTEIN, THE CODED PROTEINS, AND THEIR THERAPEUTIC APPLICATIONS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
D17 | Declaration under article 17(2)a | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |